(Press-News.org) BOSTON (July 24, 2012, 5:00PM EST)—A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer's disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow the progression of Alzheimer's disease.
"A moderate-to-severe TBI, or head trauma, is one of the strongest environmental risk factors for Alzheimer's disease. A serious TBI can lead to a dysfunction in the regulation of the enzyme BACE1. Elevations of this enzyme cause elevated levels of amyloid-beta, the key component of brain plaques associated with senility and Alzheimer's disease," said first author Kendall Walker, PhD, postdoctoral associate in the department of neuroscience at Tufts University School of Medicine (TUSM).
Building on her previous work, neuroscientist Giuseppina Tesco, MD, PhD, of Tufts University School of Medicine (TUSM), led a research team that first used an in vivo model to determine how a single episode of TBI could alter the brain. In the acute phase (first two days) following injury, levels of two intracellular trafficking proteins (GGA1 and GGA3) were reduced, and an elevation of BACE1 enzyme level was observed.
Next, in an analysis of post-mortem brain samples from patients with Alzheimer's disease, the researchers found that GGA1 and GGA3 levels were reduced while BACE1 levels were elevated in the brains of Alzheimer's disease patients compared to the brains of people without Alzheimer's disease, suggesting a possible inverse association.
In an additional experiment using a mouse strain genetically modified to express the reduced level of GGA3 that was observed in the brains of Alzheimer's disease patients, the team found that one week following traumatic brain injury, BACE1 and amyloid-beta levels remained elevated even when GGA1 levels had returned to normal. The research suggests that reduced levels of GGA3 were solely responsible for the increase in BACE 1 levels and therefore the sustained amyloid-beta production observed in the sub-acute phase, or seven days, after injury.
"When the proteins are at normal levels, they work as a clean-up crew for the brain by regulating the removal of BACE1 enzymes and facilitating their transport to lysosomes within brain cells, an area of the cell that breaks down and removes excess cellular material. BACE1 enzyme levels may be stabilized when levels of the two proteins are low, likely caused by an interruption in the natural disposal process of the enzyme," said Tesco, assistant professor of neuroscience at Tufts School of Medicine and member of the neuroscience program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts.
"We found that GGA1 and GGA3 act synergistically to regulate BACE1 post-injury. The identification of this interaction may provide a drug target to therapeutically regulate the BACE1 enzyme and reduce the deposition of amyloid-beta in Alzheimer's patients," she continued. "Our next steps are to confirm these findings in post-mortem brain samples from patients with moderate-to-severe traumatic brain injuries."
Moderate-to-severe TBIs are caused most often by traumas, such as severe falls or motor vehicle accidents, that result in a loss of consciousness. Not all traumas to the head result in a TBI. According to the Centers for Disease Control and Prevention, each year 1.7 million people sustain a TBI. Concussions, the mildest form of a TBI, account for about 75% of all TBIs. Studies have linked repeated head trauma to brain disease and some previous studies have linked single events of brain trauma to brain disease, such as Alzheimer's. Alzheimer's disease currently affects as many as 5.1 million Americans and is the most common cause of dementia in adults age 65 and over.
###Additional authors on the study are Eugene Kang, MPH, research assistant in the department of neuroscience at TUSM; Michael Whalen, MD, PhD, Neuroscience Center and department of pediatrics at Massachusetts General Hospital and associate professor at Harvard Medical School; and Yong Shen, MD, PhD, of the Center for Advanced Therapeutic Strategies for Brain Disorders at Roskamp Institute.
This study was supported by grants from the National Institute on Aging (#AG033016 and #AG025952), part of the National Institutes of Health; and a grant from the Cure Alzheimer's Fund.
Walker KR, Kang EL, Whalen MJ, Shen Y, Tesco G. The Journal of Neuroscience. "Depletion of GGA1 and GGA3 mediates post-injury elevation of BACE1." Published online July 25, 2012, DOI: 0.1523/JNEUROSCI.5491-11.2012
About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences
Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts University are international leaders in innovative medical education and advanced research. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level. Ranked among the top in the nation, the School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its effect on the advancement of medical science.
New research determines how a single brain trauma may lead to Alzheimer's disease
2012-07-25
ELSE PRESS RELEASES FROM THIS DATE:
New publication examines effect of early drug administration on Alzheimer's animal model
2012-07-25
LEXINGTON, Ky. (July 25, 2012) — In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease. The drug, called MW-151, is a selective suppressor of brain inflammation and overproduction of proinflammatory molecules from glial ...
EARTH: 2012
2012-07-25
Alexandria, VA – December 21, 2012 – the purported last day of a 5,125-year cycle in the Mesoamerican calendar – has been added to an endless list of days when the world has been expected to end. But what are our real chances of being wiped out by a catastrophic event – the kind that has happened in the past and will inevitably occur again someday? In the August issue of EARTH, we explore four of the most probable global events that could change life on Earth forever.
Near-Earth objects (NEOs), super-eruptions, solar storms and cataclysmic earthquakes all pose serious ...
Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
2012-07-25
University of Michigan heart researchers are shedding light on a safer method for steadying an abnormal heart rhythm that prevents collateral damage to healthy cells.
Irregular heart rhythms, or arrhythmias, set the stage for a common, debilitating disorder called atrial fibrillation that puts adults as young as age 40 at risk for fatigue, fainting, cardiac arrest, and even death. Medications can help, but doctors also use catheter ablation in which electrical impulses are delivered to a region of the heart to disrupt the arrhythmia.
However, studies show half of patients ...
Male Ontario students show declines in fighting; females show elevated bullying and mental distress
2012-07-25
For Immediate Release – July 24, 2012 – (Toronto) – An ongoing survey of Ontario students in grades 7 to 12 conducted for the Centre for Addiction and Mental Health (CAMH) shows that while the majority of students have healthy relationships and report overall good mental and physical health, some negative trends, especially among girls, have raised concerns.
The 2011 Ontario Student Drug Use and Health Survey (OSDUHS) Mental Health and Well-Being Report released today reveals important trends in mental and physical health and risk behaviours among Ontario students.
Psychological ...
Super Bags to thwart rice wastage now available to Filipino farmers
2012-07-25
An airtight, reusable plastic bag that protects stored rice from moisture, pests, and rats, and keeps rice seeds viable, is now available to Filipino farmers in almost 200 retail stores nationwide.
IRRI Super Bags reduce losses incurred after harvest that usually stem from poor storage conditions – helping prevent physical postharvest losses that can be around 15%. On top of these losses, farmers also experience loss in quality.
Developed by the International Rice Research Institute (IRRI)'s postharvest experts in collaboration with GrainPro Inc., the IRRI Super Bag ...
Bend or stretch? How stressful is hyperflexion of horses' necks?
2012-07-25
Arguments over how best to train horses have raged for centuries. Two years ago, the International Equestrian Federation (FEI) was even moved to ban the practice of hyperflexion as a result of a petition signed by over 40,000 people claiming that it caused the animals unnecessary discomfort. The FEI did make a distinction between hyperflexion by the use of extreme force and what it termed "low, deep and round" (LDR), which essentially achieves the same position without force. How forceful hyperflexion should be distinguished from permissible LDR training was not clearly ...
ESC says 50 percent of CVD deaths in Europe could be avoided with proper regulation
2012-07-25
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
Cardiovascular disease is still the main cause of death in Europe, leading to more than 4.3 million deaths each year and costing at least €190 billion. But 80-90% of all cardiovascular ...
UK research paves way to a scalable device for quantum information processing
2012-07-25
Researchers at NPL have demonstrated for the first time a monolithic 3D ion microtrap array which could be scaled up to handle several tens of ion-based quantum bits (qubits). The research, published in Nature Nanotechnology, shows how it is possible to realise this device embedded in a semiconductor chip, and demonstrates the device's ability to confine individual ions at the nanoscale.
As the UK's National Measurement Institute, NPL is interested in how exotic quantum states of matter can be used to make high precision measurements, of for example, time and frequency, ...
Scientists create artificial mother of pearl
2012-07-25
Mimicking the way mother of pearl is created in nature, scientists have for the first time synthesised the strong, iridescent coating found on the inside of some molluscs. The research was published today in the journal Nature Communications.
Nacre, also called mother of pearl, is the iridescent coating that is found on the inside of some molluscs and on the outer coating of pearls. By recreating the biological steps that form nacre in molluscs, the scientists were able to manufacture a material which has a similar structure, mechanical behaviour, and optical appearance ...
Classifying neural circuit dysfunctions using neuroeconomics
2012-07-25
Philadelphia, PA, July 24, 2012 – The traditional approach to psychiatric diagnosis is based on grouping patients on the basis of symptom clusters. This approach to diagnosis has a number of problems, as symptoms are not necessarily specific to a single diagnosis. Symptoms may vary among patients with a particular diagnosis, and there are no clear diagnostic biomarkers or tests for psychiatry as there are for other areas of medicine.
With this in mind, Steve Chang, along with colleagues from Duke University, introduces a new classification scheme for psychiatric symptoms ...